Meltzer, Stephen - Johns Hopkins University

个人简介

Dr. Stephen J. Meltzer is a Professor of Medicine and Oncology at Johns Hopkins University, Division of Gastroenterology. He is the Director of GI Early Detection Biomarkers Laboratory and a member of the Johns Hopkins Kimmel Cancer Center. His research interests are Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer, Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer and gastric cancer. After receiving degree in Medicine at the State University of New York Medical School, Dr. Meltzer interned at Tulane University in New Orleans and University of Texas Medical Branch in Galveston, TX. He completed his fellowship training program in the University of Colorado and the Lenox Hill Hospital. He was an Assistant Professor in UCLA, Center for Health Science in 1987. Prior to joining the faculty at Johns Hopkins in 2006, he was Professor of Medicine and Pharmacology, Founder and Head of Aero digestive Cancer/Biomarker Program in School of Medicine, University of Maryland at Baltimore. He is an Associate Editor of Cancer Research and a member of the editorial board of Esophageal. He has published 152 original scientific papers in high-impact scientific journals. He also has 43 chapters, review articles, editorials, or letters to the editor; 1 book; and 139 abstracts to his name. He has given a plethora of invited lectures around the world, all involving his principal field of esophageal and gastrointestinal cancer research. He has been the recipient of numerous prestigious national and international awards, including the Robert and Sally D. Funderburg Award in Gastric Cancer Biology and membership in the American Society for Clinical Investigation. Special Interests: Gastrointestinal cancer and precancer biomarker discover, development and validation; genomics, epigenomics and bioinformatics, early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer. Barrett's esophagus, inflammatory bowel disease-associated cancer, liver cancer, gastric cancer

研究领域

Molecular pathophysiology and translational research in Barrett’s esophagus-associated neoplastic progression

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas KT Wilson, S Fu, KS Ramanujam, SJ Meltzer Cancer Research 58 (14), 2929-2934 Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. RF Souza, R Appel, J Yin, S Wang, KN Smolinski, JM Abraham, TT Zou, ... Nature genetics 14 (3), 255 PTEN1 is frequently mutated in primary endometrial carcinomas D Kong, A Suzuki, TT Zou, A Sakurada, LW Kemp, S Wakatsuki, ...Nature genetics 17 (2), 143-144 Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma K Kawakami, J Brabender, RV Lord, S Groshen, BD Greenwald, ... Journal of the National Cancer Institute 92 (22), 1805-1811 Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. RF Boynton, PL Blount, J Yin, VL Brown, Y Huang, Y Tong, T McDaniel, ... Proceedings of the National Academy of Sciences 89 (8), 3385-3388